Kamuvudines are a new class of drugs that are derived from the anti-HIV nucleoside reverse transcriptase inhibitors. They are designed to inhibit the inflammasome, part of the innate immune system ...

University of Pennsylvania researchers say their findings could potentially lead to the development of a blood test to monitor people at high risk of developing Type 1 diabetes. New research into ...

Telehealth replaces 74% of office visits, according to the operational analysis of telehealth utilization from 2019 to 2023, ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

Beginning Jan. 1, 2026, Optum Rx, the pharmacy benefit manager of UnitedHealthcare, will reduce reauthorizations for an ...

CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...

Ralph Abraham's appointment as CDC principal deputy director raises concerns due to his controversial vaccine stance and past actions as Louisiana's surgeon general. His appointment follows the forced ...

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...

Public health experts warn that a major communication failure could worsen mistrust of vaccines, a problem brought to light ...

The FDA has approved Itvisma (onasemnogene abeparvovec-brve) to treat children two years and older, teens, and adults living with spinal muscular atrophy (SMA). It is indicated for patients with a ...

Manufacturers may prioritize developing drugs for rare diseases first, delaying negotiations for common condition treatments. A provision in the One Big Beautiful Bill delays or exempts high-spending ...